ResMed Director Files Form 144 for $227K Proposed Share Sale

Executive Summary

On September 2, 2026, Peter C Farrell, Director at ResMed INC ($RMD), filed a Form 144 notice proposing the sale of 970 shares of common stock through Merrill Lynch, with an estimated aggregate market value of $227,608.41 ($234.65 per share).

Key Filing Details

• Insider: Peter C Farrell
• Title/Role: Director
• Securities Offered: 970 Common shares
• Aggregate Market Value: $227,608.41
• Origin of Shares: Acquired via Stock Option exercise on November 11, 2015
• Trading Plan: Pre-arranged Rule 10b5-1 trading plan adopted on August 12, 2025
• Recent Prior Sales: 8,000 shares sold on August 5, 2026, for gross proceeds of $1,799,642.92
• Shares Outstanding: 144,252,306 shares

Impact Analysis

The proposed transaction represents less than 0.001% of ResMed's outstanding common stock and is executed pursuant to a pre-established Rule 10b5-1 trading plan. Given the small transaction size and routine nature of the sale under a 10b5-1 plan, market impact is expected to be negligible.